Courts Block Better's Poison Pill, Allow Garg Proxy Fight

New York and Delaware courts have issued rulings that temporarily suspend Better's "poison pill" shareholder rights plan, a move that allows Vishal Garg to continue his proxy fight for control of the company. The decisions, made on unspecified dates, effectively block Better's attempt to thwart Garg's efforts to gain board seats and influence the company's direction. The "poison pill" is a defensive tactic designed to make a hostile takeover prohibitively expensive by allowing existing shareholders to buy additional shares at a discount if a single entity acquires a certain percentage of the company's stock. By temporarily suspending this measure, the courts have removed a significant obstacle for Garg, who has been actively seeking to challenge the current leadership and strategy of Better, an online mortgage lender.

Vishal Garg, the founder and former CEO of Better, was ousted from his CEO position in early 2023 following reports of misconduct. However, he retained a substantial ownership stake and has been engaged in a protracted battle to regain influence. His proxy fight aims to elect his preferred candidates to the company's board of directors, which he argues is necessary to steer Better back towards its original vision and improve its financial performance. The company's current leadership, including CEO Pravin Patel, has been defending against Garg's actions, viewing his attempts as disruptive and detrimental to the company's stability and ongoing recovery efforts. The "poison pill" was implemented by Better's board as a response to Garg's escalating proxy solicitation efforts, aiming to dilute his potential voting power and make his acquisition of control more difficult.

The legal challenges in both New York and Delaware courts centered on the validity and implementation of the "poison pill" and Garg's right to solicit shareholder support. The courts' temporary suspension indicates a preliminary finding that Better's defense may have been improperly enacted or that Garg's rights as a shareholder are being unfairly curtailed. This ruling does not represent a final judgment on the merits of the dispute but provides a crucial window for Garg to advance his proxy solicitation campaign. The outcome of this proxy fight could significantly alter Better's corporate governance, strategic direction, and potentially its operational leadership. The company has faced considerable financial headwinds and restructuring in recent years, making the control battle a critical juncture for its future.

Better, officially known as Better.com, is a technology-driven company that aims to simplify and streamline the mortgage and real estate process. Founded in 2014, it has grown to become a significant player in the U.S. mortgage market, leveraging technology to offer services like online mortgage applications, refinancing, and title insurance. The company has experienced rapid growth but has also faced significant challenges, including layoffs and a highly publicized, abrupt termination of employees via a Zoom call in December 2021, which drew widespread criticism. Vishal Garg's ongoing involvement highlights the deep divisions within the company and the intense personal and financial stakes involved in the battle for its future. The court's decision to temporarily lift the "poison pill" is a significant development, shifting the immediate advantage to Garg and setting the stage for a potentially decisive shareholder vote.